Zur Hauptnavigation springen Zum Hauptinhalt springen Zur Fußzeile springen

Merger Notification - Announcement according to § 10 Cartel Act

Advanced Instruments LLC; Investor AB; Nova Biomedical - BWB/Z-6904 | Bundeswettbewerbsbehörde

Advanced Instruments LLC; Investor AB; Nova Biomedical

BWB/Z-6904

04.04.2025

On 03.04.2025 the Austrian Federal Competition Authority was notified of the following merger:

Planned purchase process

Advanced Instruments LLC (Norwood -MA / USA), an indirect subsidiary of Investor AB (Stockholm / Sweden) intends to acquire 100% of the shares in and sole control over Nova Biomedical Corporation and its
subsidiaries (Waltham - MA / USA). The concentration concerns analytical instruments and consumables for biopharmaceutical and clinical markets.  

ÖNACE 2025: Manufacture of medical and dental equipment and materials.

C - MANUFACTURING C 32 - Other manufacturing, C 32.5 - Manufacture of medical and dental instruments and supplies, C 32.50 - Manufacture of medical and dental instruments and supplies

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 02.05.2025.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 03.05.2025 .

back to list